METASTATIC THYMIC CARCINOMA
Clinical trials for METASTATIC THYMIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC THYMIC CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC THYMIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for rare thymic cancer
Disease control CompletedThis study tested a combination of two drugs, pembrolizumab and lenvatinib, in 43 people with advanced thymic carcinoma or a related thymoma that had worsened after standard chemotherapy. The goal was to see if the combination could slow or stop cancer growth. Participants receiv…
Matched conditions: METASTATIC THYMIC CARCINOMA
Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Promising new combo for rare thymic cancer shows potential
Disease control CompletedThis study tested whether adding the drug ramucirumab to standard chemotherapy (carboplatin and paclitaxel) helps people with advanced thymic cancer that cannot be surgically removed. The trial included 21 patients with cancer that had spread or returned. The goal was to see if t…
Matched conditions: METASTATIC THYMIC CARCINOMA
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 11, 2026 20:47 UTC